ArticlePlanta2026
Metabolic engineering of Nicotiana benthamiana for production of curcuminoids.
Article in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MAIN
conclusionNicotiana benthamiana plants transiently transformed with the C4 vector are capable to produce curcumin, demethoxycurcumin and bisdemethoxycurcumin in reasonable yields. Curcuminoids are valuable bioactive compounds whose heterologous production remains limited by precursor availability, cytotoxic intermediates and imbalanced metabolite ratios in microbial systems. In this study, we employed Nicotiana benthamiana as a platform for the transient expression of turmeric polyketide synthases, including diketide-CoA synthase (DCS) and curcumin synthases 1-3 (CURS1-3). Using Agrobacterium tumefaciens and a polycistronic expression vector (C4), we achieved the coordinated production of curcumin [187.7 ± 4.6 µg/g dry weight (DW)], demethoxycurcumin (41.8 ± 2.3 µg/g DW) and bisdemethoxycurcumin (31 ± 4.6 µg/g DW). Notably, the relative proportions of these metabolites closely matched those found in turmeric rhizomes. Metabolite identity was confirmed by chromatographic and spectroscopic analyses. These results demonstrate that plant-based transient expression systems can overcome key limitations of microbial platforms and enable the production of curcuminoids in physiologically relevant ratios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.